[{"address1": "1500 District Avenue", "city": "Burlington", "state": "MA", "zip": "01803", "country": "United States", "phone": "617 600 7373", "website": "https://www.minervaneurosciences.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. The company has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.", "fullTimeEmployees": 9, "companyOfficers": [{"maxAge": 1, "name": "Dr. Remy  Luthringer Ph.D.", "age": 62, "title": "Executive Chairman & CEO", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 1274649, "exercisedValue": 0, "unexercisedValue": 34200}, {"maxAge": 1, "name": "Mr. Geoffrey Robin Race F.C.M.A., M.B.A.", "age": 62, "title": "President", "yearBorn": 1961, "fiscalYear": 2023, "totalPay": 913302, "exercisedValue": 0, "unexercisedValue": 28880}, {"maxAge": 1, "name": "Mr. Frederick W. Ahlholm CPA", "age": 57, "title": "Senior VP, CFO & Secretary", "yearBorn": 1966, "fiscalYear": 2023, "totalPay": 726017, "exercisedValue": 0, "unexercisedValue": 19760}, {"maxAge": 1, "name": "Mr. Joseph  Reilly", "age": 48, "title": "Senior VP & COO", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 460999, "exercisedValue": 0, "unexercisedValue": 632717}, {"maxAge": 1, "name": "Mr. William B. Boni", "age": 71, "title": "Vice President of Investor Relations & Corporate Communications", "yearBorn": 1952, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Michael  Davidson M.D.", "age": 73, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2023, "totalPay": 657466, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.66, "open": 2.6, "dayLow": 2.5684, "dayHigh": 2.6747, "regularMarketPreviousClose": 2.66, "regularMarketOpen": 2.6, "regularMarketDayLow": 2.5684, "regularMarketDayHigh": 2.6747, "beta": 0.129, "forwardPE": -1.315271, "volume": 21818, "regularMarketVolume": 21818, "averageVolume": 15585, "averageVolume10days": 14130, "averageDailyVolume10Day": 14130, "bid": 1.86, "ask": 3.36, "bidSize": 200, "askSize": 200, "marketCap": 18672406, "fiftyTwoWeekLow": 2.26, "fiftyTwoWeekHigh": 13.49, "fiftyDayAverage": 2.72368, "twoHundredDayAverage": 3.831525, "currency": "USD", "enterpriseValue": 74230568, "floatShares": 5436884, "sharesOutstanding": 6993410, "sharesShort": 9614, "sharesShortPriorMonth": 10899, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.0014, "heldPercentInsiders": 0.22257, "heldPercentInstitutions": 0.29833, "shortRatio": 0.93, "shortPercentOfFloat": 0.0023999999, "bookValue": -6.362, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -33645196, "trailingEps": -4.4, "forwardEps": -2.03, "enterpriseToEbitda": -2.833, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "NERV", "underlyingSymbol": "NERV", "shortName": "Minerva Neurosciences, Inc", "longName": "Minerva Neurosciences, Inc.", "firstTradeDateEpochUtc": 1404221400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "ceeb0642-b36f-3eda-bb3a-75cdc1b13e8a", "gmtOffSetMilliseconds": -14400000, "currentPrice": 2.67, "targetHighPrice": 5.0, "targetLowPrice": 5.0, "targetMeanPrice": 5.0, "targetMedianPrice": 5.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 30881000, "totalCashPerShare": 4.416, "ebitda": -26205152, "totalDebt": 86579048, "quickRatio": 7.347, "currentRatio": 7.472, "returnOnAssets": -0.28884, "freeCashflow": -17926034, "operatingCashflow": -20829020, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-17"}]